期刊文献+

探讨化疗灌注结合益气活血汤在中晚期膀胱癌治疗中的效果 被引量:2

Efficacy of chemotherapy plus the Yiqi Huoxue decoction on advanced bladder cancer
下载PDF
导出
摘要 目的:探讨化疗灌注结合益气活血汤在中晚期膀胱癌治疗中的效果。方法:选取来我院治疗的中晚期膀胱癌患者180例,按照随机原则分为观察组和对照组,每组各90例。两组患者均给予双侧髂内动脉化疗灌注治疗,观察组患者在治疗基础上再给予益气活血汤。结果:观察组患者治疗后CD4+、CD8+、NK细胞指标与治疗前相比显著改善,比较差异具有统计学意义(P<0.05),对照组患者治疗前后CD4+、CD8+、NK细胞指标无显著改善,比较差异不具有统计学意义(P>0.05)。观察组患者的生存率为98.9%,显著高于对照组患者的91.1%,比较差异具有显著性(P<0.05)。结论:化疗灌注结合益气活血汤治疗中晚期膀胱癌能够促进患者康复,提高患者生存率。 Objective: To explore efficacy of chemotherapy plus the Yiqi Huoxue decoction on advanced bladder cancer. Methods: 180 cases were divided into the observed group and control group, 90 cases in each. Both groups received internal iliac arterial infusion chemotherapy. The observed group took the Yiqi Huoxue decoction more. Results: After treatment, in the observed group, CD4+, CD8+ and NK were more obviously improved than before treatment(P〈0.05); in the control group, the difference of CD4+, CD8+ and NK between before and after treatment was not significant(P〈0.05). The efficiency was 98.9% in the observed group, obviously better than 91.1% in the control group(P〈0.05). Conclusion: Chemotherapy plus the Yiqi Huoxue decoction was effective on advanced bladder cancer, can promote recovery of body and improve efficiency.
作者 王宏吉
出处 《中医临床研究》 2016年第2期84-85,共2页 Clinical Journal Of Chinese Medicine
关键词 化疗灌注 益气活血汤 中晚期 膀胱癌 效果 Chemotherapy The Yiqi Huoxue decoction Middle and advanced stage Bladder cancer Effects
  • 相关文献

参考文献4

二级参考文献28

  • 1蔡丹,王志华,胡志全,张旭,周四维,叶章群.膀胱癌患者外周血树突状细胞的体外培养扩增和鉴定[J].中华泌尿外科杂志,2006,27(7):472-474. 被引量:2
  • 2李家邦,祝赛君.生血宝治疗放化疗后白细胞减少症106例疗效观察[J].中国中西医结合杂志,1996,16(12):753-753. 被引量:4
  • 3MESSING E M.Urothelial tumors of the urinary tract[M] //Campbell's urology.8th ad.WALSH P C,RETIK A B,VAUGHAN E D J R,WEIN A J,eds.Philadelphia(PA):W.B.Saunders,2002:2732-2784.
  • 4RO J Y,STAERKEL G A,AYALA A G.Cytologic and histologic features of superficial bladder cancer[J].Urol Clin North Am,1992,19(3):435-553.
  • 5BRAUSI M,CLLETE L,KURTH K.Variability in the recurrencen rate at first follow-up cystescopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder:a combined analysis of seven EORTC studies[J].Eur Urol,2002,41:523-531.
  • 6KURODA M,NIJIMAT,KOTAKET,et al.Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer.The 6th Trial of the Japanese Urological Cancer Research Group(JUCRG):a randomized trial of intravesical epirubicin at dose of 20mg/40ml,30mg/40ml,40 mg/40 mL[J].Eur Urol,2004,45:600-605.
  • 7Grimm MO, Steinhoff C, Simon X, et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol, 2003, 170: 433-437.
  • 8Sobin LH, Wittekind Ch. TNM classification of malignant tumours. 6th ed. Wiley-Liss: New York, 2002: 199-202.
  • 9冯作化,皇普系穆.分子生物学基本实验技术.北京:人民卫生出版社,2000:6.
  • 10Kurth KH, Bouffioux C, Sylvester R, et al. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol, 2000, 37 (Suppl 3 ) : 1-9.

共引文献31

同被引文献55

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部